ASARINA PHARMA
Asarina Pharma AB is a Swedish biotech company focusing on the development of Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder and other menstrually related conditions. The company's primary goal is to offer a novel therapy that is specifically designed for PMDD. Asarina has a second generation oral compound in preclinical development for PMDD
ASARINA PHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.asarinapharma.com
Total Employee:
1+
Status:
Active
Contact:
+46 8 524 844 84
Total Funding:
24.83 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Font Awesome GStatic Google Static Content WordPress 6.4 Umami
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Current Employees Featured
Founder
Stock Details
Investors List
Rosetta Capital
Rosetta Capital investment in Post-IPO Equity - Asarina Pharma
Kurma Partners
Kurma Partners investment in Post-IPO Equity - Asarina Pharma
Idinvest Partners
Idinvest Partners investment in Post-IPO Equity - Asarina Pharma
Idinvest Partners
Idinvest Partners investment in Venture Round - Asarina Pharma
Kurma Partners
Kurma Partners investment in Venture Round - Asarina Pharma
Rosetta Capital
Rosetta Capital investment in Venture Round - Asarina Pharma
Karolinska
Karolinska investment in Venture Round - Asarina Pharma
Kurma Partners
Kurma Partners investment in Venture Round - Asarina Pharma
Official Site Inspections
http://www.asarinapharma.com
- Host name: linux1.curanet.dk
- IP address: 94.231.106.219
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Asarina Pharma"
About Us - Asarina Pharma
Management. With rich business and medical expertise, the Asarina Pharma team is united by its vision of bringing a new family of safe, natural, effective compounds—GAMSAs—to market for …See details»
Asarina Pharma - Crunchbase Company Profile
Asarina Pharma AB is a Swedish biotech company focusing on the development of Sepranolone (UC1010) for the treatment of premenstrual dysphoric disorder …See details»
Asarina Pharma
Asarina Pharma-aktierna avnoterades från NASDAQ First North i oktober 2024 efter att en extra bolagsstämma beslutade att likvidera företaget.See details»
Investor Relations - Asarina Pharma
[email protected]. Otto Skolling CBO Mob + 46 768 030 181 [email protected]. CERTIFIED ADVISOR. The Company’s Certified Adviser …See details»
Asarina Pharma - businessabc.net
Feb 25, 2025 https://www.asarinapharma.com. Overview. Location. Table of content . Summary. History. Mission. Vision. Key Team. Recognition and Award. References. Summary. Asarina …See details»
Asarina Pharma 2025 Company Profile: Stock …
Asarina Pharma General Information Description. Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders.See details»
Asarina Pharma - Craft
Asarina Pharma is a company that develops treatments for premenstrual dysphoric syndrome and menstrual-related diseases. It provides Sepranolone, a non-hormonally active compound that …See details»
Asarina Pharma - Overview, News & Similar companies - ZoomInfo
Apr 27, 2023 www.asarinapharma.com. Revenue <$5 Million. Stock Symbol APS.F. Industry Manufacturing General Manufacturing . Recent News & Media. Asarina Pharma’s positive …See details»
Asarina Pharma AB:Company Profile & Technical …
Asarina Pharma AB is a company that provides Medicine, Asarina, Premenstrual dysphoric disorder and more. Asarina Pharma AB is headquartered in Sweden .See details»
Investors - Asarina Pharma
JOIN US. Thank you for your interest in investing in Asarina Pharma, and helping us develop a new family of safe, natural, effective compounds, GAMSAs, for the treatment of stress- and …See details»
Asarina Pharma - LinkedIn
Asarina Pharma | 810 followers on LinkedIn. We're developing Sepranolone, a safe endogenous compound for the treatment of Menstrual Migraine and Tourette. | Asarina Pharma is …See details»
Company Asarina Pharma AB Deutsche Boerse AG
Dec 31, 2017 Asarina Pharma AB (publ), formerly Umecrine Mood, is a Sweden-based biotech company within area of womenâ s health. The Companyâ s main product is Sepranolone, a …See details»
REMAIN IN CONTROL OF YOUR LIFE
Www.asarinapharma.com SO BEGAN A 40-YEAR, 400-PAPER RESEARCH JOURNEY UNLOCKING THE REASONS WHY UNLOCKING NEW POTENTIAL IN WOMEN’S HEALTH …See details»
Asarina Pharma - Products, Competitors, Financials, Employees ...
Asarinapharma.com. Overview & Products; Financials; Founded Year 2006. Stage IPO | IPO. Total Raised $7.7M. Date of IPO 9/24/2018. Market Cap 0.00B. Stock Price 0.03. About …See details»
Asarina Pharma AB - Drug pipelines, Patents, Clinical trials - Synapse
Www.asarinapharma.com. Last update 07 Mar 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
Company Asarina Pharma AB - MarketScreener.com
Dec 31, 2017 Asarina Pharma AB (publ), formerly Umecrine Mood, is a Sweden-based biotech company within area of womenâ s health. The Companyâ s main product is Sepranolone, a …See details»
Asarina Pharma - VentureRadar
Website: http://www.asarinapharma.com/ We’re developing Sepranolone, the world’s first dedicated treatment for PMDD, the severest form of PMS. 1-in-20 women of a ...See details»
Press Releases - Asarina Pharma
Sep 13, 2024 Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.See details»
Asarina Pharma AB (publ) releases Annual Report 2022
(Stockholm, 28 April 2023) Asarina Pharma’s 2022 Annual Report contains analysis and insights into its recent positive Phase IIa results for Tourette syndrome, as well as 2022 financial …See details»
News - Asarina Pharma
Jul 22, 2024 Asarina Pharma is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion, menstrual and neurological disorders.See details»